Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1336 EUR | +2.93% | -0.30% | +26.04% |
Business Summary
All sales are abroad.
Number of employees: 3
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Medicines
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -98.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 18-06-30 |
Bruno Besse
CTO | Chief Tech/Sci/R&D Officer | - | 17-02-28 |
Chief Tech/Sci/R&D Officer | - | - | |
General Counsel | - | 22-05-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - | |
Director/Board Member | 58 | - | |
François Durvye
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,854,981 | 30,403,091 ( 87.23 %) | 0 | 87.23 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.04% | 9.83M | |
+42.43% | 54.04B | |
+43.57% | 41.96B | |
-1.15% | 41.92B | |
-7.59% | 28.35B | |
+11.82% | 26.35B | |
-22.30% | 19B | |
+7.82% | 13B | |
+28.83% | 12.28B | |
+25.47% | 12.19B |
- Stock Market
- Equities
- ALQGC Stock
- Company Quantum Genomics